US industry opposes use of specific language in new informed consent rule
This article was originally published in RAJ Devices
Executive Summary
Proposals by the US Food and Drug Administration to amend the informed consent requirements to increase awareness about the publicly accessible clinical trials registry, ClinicalTrials.gov, has drawn concern from the medtech industry1,2.